Inside Innovation

Seattle-based Proprio, a startup using artificial intelligence to improve surgical precision, announced its second major clearance from the U.S. Food and Drug Administration to include

Bristol Myers Squibb recently announced it will invest $40 billion in the U.S. over the next five years to expand its research and manufacturing presence.

Headquartered in Seattle, AGC Biologics has entered a multiphase partnership with Novelty Nobility Inc., a clinical-stage biotech company based in South Korea. As part of

Microsoft’s AI for Good Lab has awarded $5 million over two years to 20 Washington-based organizations to help solve today’s toughest challenges through innovative, tech-driven

Spokane-based startup Gestalt Diagnostics announced it has raised $7.5 million to enhance its artificial intelligence tools for digital pathology analysis. The new funding will support

Life Science Washington, the state’s industry trade association, today released its annual Economic Impact Report, revealing a 50% increase in job growth from 2013 to

At Life Science Innovation Northwest (LSINW) 2025, Dr. David Baker, Nobel Laureate and Director of the Institute for Protein Design at the University of Washington,

Fred Hutch Cancer Center and UW Medicine researchers Dr. Megan Shen and Dr. Mary L. “Nora” Disis were awarded $300,000 each by the Rivkin Center

Scientists from Seattle’s Allen Institute played a key role in accomplishing a feat that was said to be impossible 46 years ago: mapping the cells

Life Science Washington Institute (LSWI), in partnership with the Washington State Department of Commerce, announced the completion of the second and final year of the

Curi Bio, a Seattle-based biotech company, has settled into its new 13,942-square-foot space in Interbay. Founded in 2016, Curi Bio makes stem cell-based tissue models

The Allen Institute for AI (Ai2) is joining the Cancer AI Alliance, a national initiative led by Fred Hutch Cancer Center to accelerate cancer research